Tyme Technologies Inc (NASDAQ:TYME) Major Shareholder Sells $24,400.00 in Stock

Tyme Technologies Inc (NASDAQ:TYME) major shareholder Michael Demurjian sold 20,000 shares of the company’s stock in a transaction that occurred on Monday, July 27th. The shares were sold at an average price of $1.22, for a total value of $24,400.00. Following the completion of the transaction, the insider now directly owns 25,418,546 shares in the company, valued at $31,010,626.12. The transaction was disclosed in a filing with the SEC, which is available at this link. Large shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.

Michael Demurjian also recently made the following trade(s):

  • On Monday, July 20th, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The stock was sold at an average price of $1.24, for a total value of $24,800.00.
  • On Monday, July 13th, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The shares were sold at an average price of $1.20, for a total value of $24,000.00.
  • On Monday, July 6th, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The shares were sold at an average price of $1.32, for a total value of $26,400.00.
  • On Monday, June 22nd, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The stock was sold at an average price of $1.36, for a total value of $27,200.00.
  • On Monday, June 15th, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The stock was sold at an average price of $1.35, for a total transaction of $27,000.00.
  • On Monday, June 8th, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The shares were sold at an average price of $1.53, for a total transaction of $30,600.00.
  • On Monday, June 1st, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The stock was sold at an average price of $1.50, for a total transaction of $30,000.00.
  • On Tuesday, May 26th, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The shares were sold at an average price of $1.62, for a total value of $32,400.00.
  • On Monday, May 18th, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The stock was sold at an average price of $1.62, for a total value of $32,400.00.
  • On Monday, May 11th, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The shares were sold at an average price of $1.40, for a total value of $28,000.00.

NASDAQ:TYME opened at $1.22 on Friday. The stock has a 50-day simple moving average of $1.30 and a two-hundred day simple moving average of $1.33. The firm has a market capitalization of $153.19 million, a PE ratio of -6.78 and a beta of 0.97. Tyme Technologies Inc has a 52-week low of $0.86 and a 52-week high of $2.04.

Tyme Technologies (NASDAQ:TYME) last posted its quarterly earnings data on Wednesday, May 20th. The company reported ($0.04) EPS for the quarter, topping the consensus estimate of ($0.07) by $0.03. On average, equities analysts anticipate that Tyme Technologies Inc will post -0.28 earnings per share for the current year.

A number of large investors have recently modified their holdings of the business. Nuveen Asset Management LLC raised its position in shares of Tyme Technologies by 17.8% during the 1st quarter. Nuveen Asset Management LLC now owns 250,741 shares of the company’s stock valued at $276,000 after purchasing an additional 37,862 shares during the period. UBS Group AG lifted its position in shares of Tyme Technologies by 49.1% in the fourth quarter. UBS Group AG now owns 90,630 shares of the company’s stock valued at $127,000 after acquiring an additional 29,829 shares in the last quarter. Goldman Sachs Group Inc. boosted its stake in shares of Tyme Technologies by 31.5% in the fourth quarter. Goldman Sachs Group Inc. now owns 42,232 shares of the company’s stock worth $59,000 after acquiring an additional 10,124 shares during the period. Geode Capital Management LLC grew its position in shares of Tyme Technologies by 5.2% during the first quarter. Geode Capital Management LLC now owns 781,500 shares of the company’s stock worth $859,000 after purchasing an additional 38,310 shares in the last quarter. Finally, Spark Investment Management LLC bought a new stake in Tyme Technologies during the 1st quarter valued at approximately $60,000. 11.89% of the stock is currently owned by institutional investors and hedge funds.

Several research analysts have issued reports on TYME shares. Zacks Investment Research raised Tyme Technologies from a “sell” rating to a “hold” rating in a research report on Tuesday, July 21st. HC Wainwright reissued a “buy” rating and issued a $9.50 price objective on shares of Tyme Technologies in a report on Thursday, May 21st. Finally, Canaccord Genuity reaffirmed a “buy” rating on shares of Tyme Technologies in a report on Monday, June 29th.

Tyme Technologies Company Profile

Tyme Technologies, Inc, a clinical-stage biotechnology company, develops novel cancer therapeutics. It is developing SM-88, a combination therapy based on dysfunctional metyrosine derivatives in Phase II development for metastatic pancreatic cancer and biomarker-recurrent prostate cancer. The company was founded in 2011 and is headquartered in New York, New York.

Recommended Story: Day Trading

Insider Buying and Selling by Quarter for Tyme Technologies (NASDAQ:TYME)

Receive News & Ratings for Tyme Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tyme Technologies and related companies with MarketBeat.com's FREE daily email newsletter.